Diazoxide choline extended-release tablet in people with Prader-Willi Syndrome: A double-blind, placebo-controlled trial
Essential for maintaining sterile technique when drawing from reconstituted vials
In practical terms, it should include a review of weight history, present symptoms, comorbidities, diabetes status or prediabetes risk, current medications, prior weight-loss attempts, gastrointestinal history, pregnancy considerations, thyroid cancer and MEN2 history, gallbladder history, retinal history if diabetic, and any insulin or sulfonylurea use
For physicians that treat it and their patients, understanding how a therapy alters BMR is essential for selecting optimal regimens and monitoring outcomes
Unlike fad diets and temporary fixes, medical weight loss is a personalized approach that targets the root causes of weight gain, such as hormonal imbalances, slow metabolism, and lifestyle habits
Most patients experience gradual weight regain within months of stopping tirzepatide, though the rate and extent varies individually